Microorganisms in the gut emerge as a potential determining factor for understanding the links between stress response and brain function. New findings highlight the role of gut microbiota as a central regulator of the stress-circadian axis.
Unlocking the diagnostic and therapeutic potential roles of gut microbiome: takeaways from the 2024 GMFH Summit
23 May 2024by Joël Doré, Andreu Prados
The last 12th Gut Microbiota for Health World Summit took place 23-24 March 2024 in Washington, D.C. and focused on relevant gut microbiome advances from the lab to the clinic. Find out more about the main takeaways of the conference and how they might affect your research and practice.
Why addressing how our brain and our gut talk to each other matter for IBS
19 Feb 2024by Premysl Bercik, Andreu Prados
While the idea that our gut can influence our brain is not new, this is a rapidly growing area of research. Find out more on how gut microbes influence anxiety and stress and why tackling these psychological traits matters for irritable bowel syndrome.
Where are we on microbiome-based therapies in disorders of gut-brain interaction?
4 Dec 2023by Andreu Prados, Rene van den Wijngaard
NeuroGASTRO 2023, the leading meeting in Europe held by ESNM on the latest developments in neurogastroenterology, digestive motility, and disorders of gut-brain interaction, took place from August 31st to September 2nd, 2023. Find out more about the main takeaways from the role of fecal microbiota transplants, microbial consortia and probiotics in disorders of gut-brain interaction picked up by GMFH editors (Part 2).
Research highlights from NeuroGASTRO 2023: food, mast cells, eosinophils and gut barrier in disorders of gut-brain interaction
6 Nov 2023by Andreu Prados, Rene van den Wijngaard
NeuroGASTRO 2023, the leading meeting in Europe held by ESNM on the latest developments in neurogastroenterology, digestive motility, and disorders of the gut-brain interaction, took place from August 31st to September 2nd, 2023. Find out more what the latest research says about the involvement of the intestinal microbiota, mast cells, eosinophils and gut barrier in disorders of gut-brain interaction and dietary considerations in their management picked up by GMFH editors (Part 1).
Microbiome and microbial therapy advances: takeaways from the Digestive Disease Week 2023
4 Jul 2023by Andreu Prados, Konstantina Zafeiropoulou
The DDW meeting 2023 covered a huge variety of basic, translational and clinical aspects of research in gastrointestinal and extraintestinal human health and disease. This post highlights the major-takeaways from the Microbiome & Microbial Therapy sessions and unravels how they might impact daily basic research and clinical practice (part 1).
Where do we stand in the management of IBS? Highlights from “IBS days 2022” in Bologna
18 Jul 2022by Giada De Palma
The third edition of IBS DAYS 2022 provided current advances and a look to future therapeutic approaches on the rapidly advancing field of irritable bowel syndrome. This article summarizes major highlights on diet and gut microbiome interactions of relevance for IBS.
The brain-gut-microbiota axis involves different routes of communication and can be targeted to influence brain and behavior
20 May 2022by Andreu Prados
The gut-brain connection is largely shaped by the composition and function of gut-dwelling microbial communities. This review article addresses how the brain and gut communicate and considers potential psychobiotic therapies.
Analysing the molecular and biochemical mechanisms disturbing the complex network of communication is key to our understanding of the pathophysiology of the functional GI disorders. Together with ESNM we have prepared an exciting webinar series under the topic: Microbiota and Gut-Brain Connection: A new Frontier in Neurogastroenterology. This free resource is a great opportunity to hear leading worldwide experts presenting the most recent findings on this topic.
It still too early to use probiotics, prebiotics and fermented foods for cognitive performance, concludes a new meta-analysis of randomized controlled trials
23 Nov 2020by GMFH Editing Team
Gut microbiome-targeted interventions are being explored as means of improving cognitive performance. A new meta-analysis of 22 randomized controlled studies has found no significant effect on improving cognition for probiotics, prebiotics and fermented foods, whether alone or used in combination.
